Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Positron Corp. (POSC : OTC)

• Company Description    Positron Corporation is engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emissiontomography technology under the trade name POSICAM systems. POSICAM systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $1.64 Daily Weekly Monthly 20 Day Moving Average: 8,557 shares Shares Outstanding: 31.41 (millions) Market Capitalization: $51.50 (millions) Beta: 0.44 52 Week High: $2.93 52 Week Low: $0.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.38% -9.99% 12 Week 4.46% -5.11% Year To Date 62.38% 34.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1777 Maryland Ave - Niagara Falls,NY 14305 USA ph: 317-576-0183 fax: 630-537-1249 investor@positron.com http://www.positron.com

• General Corporate Information    Officers Adel Abdullah - President/Chairman Aaron Hargrave - Vice President Tis Prager - Director Sachio Okamura - Director Dr. Anthony Nicholls - Director Peer Information Positron Corp. (ABMD) Positron Corp. (DMDS) Positron Corp. (CPWY.) Positron Corp. (EQUR) Positron Corp. (ECIA) Positron Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 737397604 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 09/17/25 Share - Related Items Shares Outstanding: 31.41 Most Recent Split Date: 4.00 (0.00:1) Beta: 0.44 Market Capitalization: $51.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/17/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 27.84 Price/Cash Flow: - Price / Sales: 93.81 EPS Growth vs. Year Ago Period: -150.00% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: -24.68% vs. Previous Quarter: -12.50% ROE 06/30/25 - -419.44 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -79.38 03/31/25 - -116.31 12/31/24 - -121.57 Current Ratio 06/30/25 - 1.93 03/31/25 - 2.69 12/31/24 - 0.62 Quick Ratio 06/30/25 - 1.37 03/31/25 - 2.04 12/31/24 - 0.04 Operating Margin 06/30/25 - - 03/31/25 - -592.35 12/31/24 - -404.93 Net Margin 06/30/25 - - 03/31/25 - -592.35 12/31/24 - -404.93 Pre-Tax Margin 06/30/25 - -719.18 03/31/25 - -593.62 12/31/24 - -406.12 Book Value 06/30/25 - 0.06 03/31/25 - 0.10 12/31/24 - -0.04 Inventory Turnover 06/30/25 - 0.66 03/31/25 - 0.84 12/31/24 - 0.74 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - - Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - -

Powered by Zacks Investment Research ©